膀胱炎症例に対するNitrofuran系化学療法剤P-6224(腸溶錠)とBromelainの併用について

Abstract

A new bacteriostatic agent of Nitrofuran derivative, P-62 2 4 (enteril tablet), was given to 56 cases of acute and chronic inflammations of the urinary bladder. In 40 cases among the total, an anti-inflammatory and anti-edematous drug, Bromelain, was combined to P-6224 in order to evaluate its clinical effectiveness. As the results, the cure rate in the groop of P6224 single therapy ranged between 62.5 and 75.0 %, which indicated that the drug is by no means inferior to the ordinal chemotherapeutic agents. The cure rate in the group of P-6224 and Bromelain combined treatment ranged between 82.5 and 87.5 %, showing that the effectiveness is larger than single treatment with P-6224. It is concluded that P-6224 is effective i n treating urinary tract infections, especially cystitis, and further excellent result is expected when it is combined with Bromelain.